By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

National Institute of Allergy And Infectious Diseases (NIAID) 

31 Center Drive MSC 2520
Building 31, Room 7A-50
Bethesda  Maryland  20892-2520  U.S.A.
Phone: 301-496-5717 Fax:


SEARCH JOBS


Industry
Healthcare


Collaborations

MedImmune, LLC 

MedImmune 





Company News
Emergent BioSolutions (EBS) Signs Agreements With Oxford University, GlaxoSmithKline (GSK), And National Institute of Allergy And Infectious Diseases (NIAID) For The Production Of An MVA Ebola Zaire Vaccine Candidate 3/16/2015 7:20:15 AM
Inovio Pharmaceuticals (INO) And Academic Collaborators Receive $16 Million HIV Grant From National Institute of Allergy And Infectious Diseases (NIAID) 3/16/2015 7:18:20 AM
Why Women May Have More Serious Allergic Reactions Than Men, National Institute of Allergy And Infectious Diseases (NIAID) Study 12/30/2014 6:29:43 AM
J. Craig Venter Institute Key Member Of Team Awarded Up To A 5-Year, $23 Million Contract From National Institute of Allergy And Infectious Diseases (NIAID) For Renewal Of Bioinformatics Resource Centers For Infectious Diseases Viral Project 11/11/2014 9:59:19 AM
Soligenix (SNGX) Awarded National Institute of Allergy And Infectious Diseases (NIAID) Contract Valued Up To $24.7 Million 9/19/2014 6:25:08 AM
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding For Manufacture And Development Of BCX4430 To Treat Hemorrhagic Virus Diseases 9/18/2014 11:20:04 AM
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of BCX4430 To Treat Hemorrhagic Fever Virus Diseases 8/13/2014 7:20:58 AM
Soligenix (SNGX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of OrbeShield™ In GI ARS 8/1/2014 7:14:57 AM
Potent HIV Antibody Research Has Opened Up Possibilities For HIV Prevention, Treatment, National Institute of Allergy And Infectious Diseases (NIAID) And Columbia University Study 3/4/2014 6:39:29 AM
Vitamin A Deficiency Promotes Type 2 Barrier Immunity, National Institute of Allergy And Infectious Diseases (NIAID) Reveals 1/24/2014 6:47:43 AM
12345678910...
//-->